Welcome to our dedicated page for MACOM Technology Solutions Holdings SEC filings (Ticker: MTSI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on MACOM Technology Solutions Holdings's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into MACOM Technology Solutions Holdings's regulatory disclosures and financial reporting.
Susan Ocampo submitted a Form 144 reporting multiple sales of Common stock between 02/03/2026 and 04/14/2026. The notice lists individual lots including 100,000 shares on 02/03/2026, 200,000 shares on 03/02/2026, and other dated sales with per‑trade proceeds also shown.
The filing lists trade dates, share counts, and gross proceeds for each lot; it is a routine Rule 144 sale notice rather than a registration or earnings disclosure.
MTSI reported multiple dispositions of Common stock by Susan Ocampo. The filing lists numerous sales on dates in February–April 2026 executed through Goldman Sachs & Co. LLC, including individual trades of 261,763 shares, 200,000 shares, and 100,000 shares.
The table shows per‑trade share quantities and corresponding gross amounts for each disposition; timing and per‑trade figures are recorded on the filing.
MTSI reporting person Susan Ocampo reported multiple disposals of Common shares via Form 144, with individual sales recorded between 02/03/2026 and 04/10/2026. The filings list specific sale transactions and share quantities, including several trades of 200,000 shares and a 261,763-share block.
Susan Ocampo reported multiple sales of Common Stock recorded on Form 144/A. The excerpt lists discrete sales across February–April 2026, including 261,763 shares on 02/25/2026, 200,000 shares on 03/02/2026, and 200,000 shares on 04/08/2026. Sale dates and per‑trade share counts are presented throughout the selling schedule.
MTSI-related Form 144: Susan Ocampo reported multiple dispositions of Common shares, with trade dates shown from 02/03/2026 through 03/25/2026. The filing lists individual sale quantities on specific dates (e.g., 100,000; 200,000; 261,763 shares).
The excerpt enumerates prior sales during the past three months by the reporting person and provides broker details for the securities to be sold.
MTSI submitted a Form 144 notice disclosing proposed sales of Common stock by an affiliate holder. The filing lists a 200,000-share Founder Shares line and multiple sale entries by Susan Ocampo with specific dates and share amounts between 02/03/2026 and 03/25/2026, including several 100,000 and 200,000-share transactions.
MACOM Technology Solutions Holdings Inc — The Vanguard Group filed Amendment No. 8 to a Schedule 13G/A stating it beneficially owns 0 shares of Common Stock, representing 0% of the class. The filing explains an internal realignment: certain Vanguard subsidiaries will report beneficial ownership separately in reliance on SEC Release No. 34-39538. The filing is signed by Ashley Grim on 03/27/2026.
The Charles Schwab Corporation reports multiple sales of Common stock by Susan Ocampo, disclosed on a Form 144. The excerpt lists dated sales including 100,000 shares on 02/03/2026, 100,000 shares on 02/06/2026 and additional transactions through 03/02/2026 (examples shown). The filing lists the issuer address and NASDAQ as the market.
MACOM Technology Solutions Holdings, Inc. director Bryan Ingram received an equity grant in the form of 776 shares of Common Stock as restricted stock units under the company’s 2021 Omnibus Incentive Plan. Each RSU converts into one share and vests in full on March 6, 2027, if he remains in continuous service. Following this grant, he holds 1,747 shares directly.
Shanmugaraj Murugesan reported acquisition or exercise transactions in this Form 4 filing.
MACOM Technology Solutions Holdings, Inc. director Shanmugaraj Murugesan received an equity award in the form of 776 restricted stock units (RSUs) of common stock. The RSUs were granted at no cash cost and will vest in full on March 6, 2027, if he remains in continuous service with the company through that date. Following this grant, Murugesan’s reported direct holdings total 6,614 shares of common stock, including the RSUs. This filing reflects a routine equity compensation award rather than an open-market stock purchase or sale.